文献速递神经肿瘤

弥漫性胶质瘤中的细胞衰老:从病理生理到可能的治疗

Cellular Senescence in Diffuse Gliomas: From Physiopathology to Possible Treatments.
PubMed 文献 · World Neurosurg · 2024-09-02

本文综述了弥漫性胶质瘤中细胞衰老的诱导机制(衰老、复制、电离辐射、致癌应激、替莫唑胺)及逃逸途径(端粒酶表达、端粒替代延长、原癌基因或抑癌基因突变),并讨论了针对衰老相关通路的衰老抑制与衰老细胞清除治疗可能改善现有治疗反应和生存率。

要点

  • 胶质瘤细胞衰老可由衰老、复制、电离辐射、致癌应激及替莫唑胺诱导。
  • 胶质瘤通过端粒酶表达、端粒替代延长及原癌/抑癌基因突变逃逸衰老。
  • 靶向衰老通路的衰老抑制与衰老细胞清除治疗可能改善治疗反应和生存率。

核心结论

  • 针对细胞衰老相关通路的衰老抑制和衰老细胞清除治疗可能改善现有治疗的反应并提高生存率。

研究设计与样本

  • 综述,总结胶质瘤中细胞衰老的诱导与逃逸机制,并回顾针对衰老相关通路的可能治疗。

主要发现

  • 胶质瘤中细胞衰老由衰老、复制、电离辐射、致癌应激和使用替莫唑胺诱导。
  • 胶质瘤逃逸衰老涉及端粒酶表达、端粒替代延长以及一些原癌基因或抑癌基因的突变。
  • 胶质瘤中这些与细胞衰老相关的分子机制可具有抑瘤或促瘤效应,并直接参与肿瘤复发和进展。

临床怎么用

  • 作者认为,从细胞衰老相关机制出发,可产生靶向的衰老抑制和衰老细胞清除治疗,以改善对现有治疗的反应并提高生存率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cellular senescence in gliomas is a complex process that is induced by aging and replication, ionizing radiation, oncogenic stress, and the use of temozolomide. However, the escape routes that gliomas must evade senescence and achieve cellular immortality are much more complex, in which the expression of telomerase and the alternative lengthening of telomeres, as well as the mutation of some proto-oncogenes or tumor suppressor genes, are involved. In gliomas, these molecular mechanisms related to cellular senescence can have a tumor-suppressing or promoting effect and are directly involved in tumor recurrence and progression. From these cellular mechanisms related to cellular senescence, it is possible to generate targeted senostatic and senolytic therapies that improve the response to currently available treatments and improve survival rates. This review aims to summarize the mechanisms of induction and evasion of cellular senescence in gliomas, as well as review possible treatments with therapies targeting pathways related to cellular senescence.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ordónez-Rubiano EG, Cómbita A, Baldoncini M, et al. Cellular Senescence in Diffuse Gliomas: From Physiopathology to Possible Treatments. World Neurosurg. 2024. PMID: 39233309. doi:10.1016/j.wneu.2024.08.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。